Evaluating blood tests for diabetes in people living with HIV
Official title: Biomarker-Guided Evaluation of Glycated Testing Modalities for Dysglycemia among Persons Living with HIV (BEGET)
Funded at University of Maryland Baltimore · NIH-10884340 · Data updated 2026-11-12
This study is looking at better ways to diagnose prediabetes and diabetes in people living with HIV, using special blood tests that work well for them, so they can get the right care sooner.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | July 10, 2023 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $175,410 |
| NIH project number | 5R21TW012658-02 |
| Project ID | NIH-10884340 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living with HIV who may be at risk for prediabetes or diabetes.
✕Less likely to help
Patients who do not have HIV or those who are not at risk for diabetes will likely not benefit from this research.
What this research studies
This research investigates how to improve the diagnosis of prediabetes and diabetes in individuals living with HIV, who are at a higher risk for these conditions. It focuses on evaluating the effectiveness of glycated hemoglobin (HbA1c) tests and fructosamine tests, which do not rely on hemoglobin levels that can be unreliable in this population. By analyzing blood samples and various biomarkers, the study aims to establish accurate diagnostic thresholds tailored for people living with HIV. This could lead to better early detection and management of diabetes in this vulnerable group.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diabetes diagnoses for individuals living with HIV, improving their overall health outcomes.
How similar studies have gone: Previous research has shown that alternative glycated tests can be effective in diagnosing diabetes in populations with specific health challenges, suggesting potential success for this approach.
Where this research is happening
-
University of Maryland Baltimore
Baltimore, United States Active
Researchers
- Principal investigator: Jumare, Jibreel — University of Maryland Baltimore
- Study coordinator: Jumare, Jibreel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.